This policy brief includes background information on Medicaid and its drug benefit, provides examples of how states are using the cost containment mechanisms at their disposal and addresses issues surrounding beneficiary access to outpatient drugs.Policy Brief
Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources
With increased national attention towards prescription drug costs, this poll examines the public’s experiences with prescription medicine and their views on current policy proposals brought forth by congressional lawmakers and the Trump administration, including international reference pricing, transparency in drug advertisements, and negotiations with drug companies. The survey also dives into the attitudes and experiences of adults, 65 and older – a group that is more likely to report taking prescription medication and shopped for prescription drug coverage.
Poll Finding See More
Related Prescription Drugs Resources
- A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
- How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
- What’s the Latest on Medicare Drug Price Negotiations?
- What are the recent and forecasted trends in prescription drug spending?
- Kaiser Health News Coverage of Prescription Drug Issues
- 10 Things to Know About Medicare Part D Coverage and Costs in 2019
- Medicaid’s Prescription Drug Benefit: Key Facts
- Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs
- How Much Does Medicare Spend on Insulin?
- How Does the Trump Administration Drug Pricing Blueprint Affect Medicaid?
- What’s in the Administration’s 5-Part Plan for Medicare Part D and What Would it Mean for Beneficiaries and Program Savings?
- Public Opinion on Prescription Drugs and Their Prices
- What Are Recent Trends and Characteristics of Workers with High Drug Spending?
- Closing the Medicare Part D Coverage Gap: Trends, Recent Changes, and What’s Ahead
- Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control
- 10 Essential Facts About Medicare and Prescription Drug Spending
- Retail Prescription Drugs Filled at Pharmacies per Capita
This animation explains how rebates for prescription drugs work and why they matter in the debate about lowering drug costs. The video breaks down how prescription drug rebates are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in…
Video See More
- view as grid
- view as list
Summarizes the coverage of outpatient prescription drugs by Medicaid. Many low-income seniors and other Medicaid recipients rely on this benefit as their only means of drug coverage. Information on the drug rebate program and utilization management procedures is included, as well as data on who uses the benefit, how much…
The Current State of Retiree Health Benefits: Findings from the Kaiser/Hewitt 2002 Retiree Health Survey
This report presents findings from a study of large private-sector employers conducted by researchers at Hewitt Associates and the Kaiser Family Foundation between July and September of 2002. The study is based on survey responses of 435 large private-sector firms (1,000+ employees) that currently offer retiree health benefits, and includes…
Health News Index May/June, 2001 The May/June 2001 edition of the Health News Index includes questions about major health stories covered in the news, including the Supreme Court ruling regarding the distribution of medical marijuana and the debate in Congress over a Patients Bill of Rights. This edition also includes…
Toplines: Seniors’ Early Experiences with the Medicare Prescription Drug BenefitThese toplines contain the detailed results from the April 2006 tracking poll on seniors’ early experiences with the new Medicare drug benefit.Toplines (.pdf)
This survey of state Medicaid pharmacy programs updates a survey conducted in 2000 and reports Medicaid prescription drug policies in effect in early 2003. It covers utilization management policies, payment and purchasing policies, utilization review policies, and policies for managed care enrollees and persons residing in institutions.Report (.pdf)
Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — May/June 2004 Kaiser Health Poll Report Survey
Topline findings from the May/June 2004 Kaiser Health Poll Report survey, including knowledge and opinions about the new Medicare prescription drug law.Survey Toplines (.pdf)
This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.Issue Brief (.pdf)
, details the different types of private plan options available to people on Medicare. These include Medicare Advantage plans (such as Medicare HMOs, PPOs and private fee-for-service plans) and new stand-alone prescription drug plans.• In 2006, all Medicare beneficiaries have access to at least one type of private Medicare Advantage…
This Medicare Part D data spotlight focuses on the use of specialty tiers for high-cost and injectible drugs in Medicare Prescription Drug Plans in 2008. It finds that the number of plans with specialty tiers has nearly doubled since 2006. It also looks at the drugs assigned to specialty tiers,…